Modulation of human corticomotor excitability by somatosensory input by �넀�쁺�샇
Somatosensory input is required for accurate motor
performance (Bastian, 1887; Pearson, 2000) and for learning
new motor skills (Pavlides et al. 1993). A reduction of this
input by local anaesthesia impairs motor control in
healthy subjects (Edin & Johansson, 1995; Aschersleben et
al. 2001). Similarly, patients with decreased somatosensory
inputs due to large-fibre sensory neuropathy display
characteristic abnormal motor behaviour (Rothwell et al.
1982; Gordon et al. 1995). In patients with stroke,
somatosensory deficits are associated with a slower
recovery of motor function (Reding & Potes, 1988).
On the other hand, it has been proposed that increased
somatosensory input in the form of peripheral nerve
stimulation may enhance motor function (Hamdy et al.
1998). In healthy subjects, a prolonged period of peripheral
nerve stimulation can induce a lasting increase in
corticomotoneuronal excitability to the stimulated body
parts (Hamdy et al. 1998; Ridding et al. 2000). In patients
with motor deficits secondary to stroke, it has been
suggested that stimulation of peripheral nerves enhances
the effectiveness of neurorehabilitation (Johansson et al.
1993; Powell et al. 1999; Wong et al. 1999; Conforto et al.
2002). The mechanisms underlying these effects are
incompletely understood.
The purpose of this study was to enhance our understanding
of the modulatory effects of somatosensory stimulation on
corticomotoneuronal excitability (Ridding et al. 2000). We
provide evidence for a cortical origin of this modulatory
effect. Further experiments indicated that it is heavily
influenced by GABAergic mechanisms.
METHODS
Subjects
Eleven healthy right-handed normal volunteers (eight males, three
females) aged 18–45 years (mean 33 years) with no history of either
neurological or psychiatric diseases participated in this study.
Handedness was evaluated by the Edinburgh Inventory (Oldfield,
1971). A complete neurological examination was normal in all
subjects. All subjects gave written informed consent. This study
was performed according to the Declaration of Helsinki and the
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In humans, somatosensory stimulation results in increased corticomotoneuronal excitability to the
stimulated body parts. The purpose of this study was to investigate the underlying mechanisms. We
recorded motor evoked potentials (MEPs) to transcranial magnetic stimulation (TMS) from
abductor pollicis brevis (APB), first dorsal interosseous (FDI), and abductor digiti minimi (ADM)
muscles. MEP amplitudes, recruitment curves (RC), intracortical inhibition (ICI), intracortical
facilitation (ICF), resting (rMT) and active motor thresholds (aMT) were recorded before and after
a 2-h period of ulnar nerve electrical stimulation at the wrist. Somatosensory input was monitored
by recording somatosensory evoked potentials. To differentiate excitability changes at cortical vs.
subcortical sites, we recorded supramaximal peripheral M-responses and MEPs to brainstem
electrical stimulation (BES). In order to investigate the involvement of GABAergic mechanisms,
we studied the influence of lorazepam (LZ) (a GABAA receptor agonist) relative to that of
dextromethorphan (DM) (an NMDA receptor antagonist) and placebo in a double-blind design.
We found that somatosensory stimulation increased MEP amplitudes to TMS only in the ADM,
confirming a previous report. This effect was blocked by LZ but not by either DM or placebo and
lasted between 8 and 20 min in the absence of (i) changes in MEPs elicited by BES, (ii) amplitudes of
early somatosensory-evoked potentials or (iii) M-responses. We conclude that somatosensory
stimulation elicited a focal increase in corticomotoneuronal excitability that outlasts the stimulation
period and probably occurs at cortical sites. The antagonistic effect of LZ supports the hypothesis of
GABAergic involvement as an operating mechanism.
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protocol was approved by the NINDS Investigational Review
Board. All subjects participated in several experiments.
Experimental protocol
Electrophysiological measurement of CM excitability by trans-
cranial magnetic stimulation (TMS) was obtained on different
days before and after one of two interventions: (a) a 2-h period of
electrical stimulation of the ulnar nerve; and (b) a 2-h idle time
(no stimulation). This latter control condition was added because
attentional and cognitive factors (Rosler et al. 1999; Rossini et al.
1999) vary during the course of the 2–3-h experiments and can
influence corticomotoneuronal excitability. Subjects sat on a
comfortable chair during all experiments.
We first identified the optimal position to stimulate the ulnar
nerve at the wrist by recording the M-response. Silver–silver
chloride electrodes (diameter 10 mm) were then placed with the
cathode proximal.
Trains of electrical stimulation were delivered at 1 Hz (Grass
stimulator S 8800 with SIU5 stimulus isolation unit, Grass
Instrument Division, Astro-Med Inc., West Warwick, RI, USA).
Each train consisted of five single pulses of 1 ms duration
delivered at 10 Hz (Ridding et al. 2000). The stimulus intensity
was adjusted to elicit small compound muscle action potentials
(CMAPs) of 50–100 µV from the ADM in the absence of visible
finger movements. This low stimulation intensity and the stimulus
duration of 1 ms preferentially activate large cutaneous and
proprioceptive sensory fibres (Panizza et al. 1992). Stimulation
was painless, comfortable, and resulted in mild paresthesias in
digits 4 and 5 (sometimes also 3). Relaxation during the 2-h period of
somatosensory stimulation was monitored by electromyography
(EMG). During the stimulation period, subjects remained seated,
reading books or magazines of their choice. They were instructed
to avoid arm movements. However, they were allowed to change
their arm position during the 2-h period if the initial position was
no longer comfortable. Supramaximal M-responses were recorded
from the abductor pollicis brevis (APB), first dorsal interosseous
(FDI), and abductor digiti minimi (ADM) muscles before and
after stimulation and idle time.
Somatosensory-evoked potentials (SEPs) during ulnar nerve
stimulation were recorded to monitor the stability of the signal
arriving in the cerebral cortex. The active recording electrode was
placed over C4‚ (2 cm posterior to C4) referenced to Fz (Terao et
al. 1999). EEG activity was pre-amplified, filtered (2 Hz–2 kHz),
and stored using a Counterpoint device (see below) and a Labview
application (Kaelin-Lang & Cohen, 2000). Peak-to-peak amplitudes
of components N20–P25 and P25–N33, thought to reflect arrival
and initial cortical processing of somatosensory input (Allison et
al. 1991; Cheron et al. 2000), were measured during and after the
2-h stimulation period.
Transcranial magnetic stimulation
Motor evoked potentials (MEPs) were recorded from APB, FDI,
and ADM muscles using silver–silver chloride electrodes in a
tendon belly arrangement on the non-dominant left hand.
EMG was pre-amplified and band-pass filtered (10 Hz–2 kHz)
using a Dantec Counterpoint electromyograph (Dantec Electronics,
Skovlunde, Denmark). Input was then fed into an IBM compatible
personal computer (486DX) with a Keithley DAS-1600 I/O board
controlled by an ‘Asyst’ application (Keithley, Taunton, MA,
USA) or to a computerized data acquisition system built with the
Labview graphical programming language (sampling rate 5 kHz)
(Kaelin-Lang & Cohen, 2000). Its ‘conditional triggering’ feature
was used to deliver TMS stimuli only when target muscles (one to
three depending on the experiment) were relaxed. Relaxation
was defined as EMG activity at baseline < 40 µV peak-to-peak
amplitude for at least 1 s. MEP amplitude was expressed relative to
the maximal peripheral M-responses. TMS was delivered to the
optimal scalp position (right motor cortex) to stimulate the
target muscle. TMS was delivered through a figure-of-eight-
shaped magnetic coil (outside diameter 8.7 cm) connected to a
Quad-module and two Magstim 200 magnetic stimulators (The
Magstim Company, Dyfed, UK). The magnetic coil was placed
tangentially to the scalp, with the intersection of both wings at a
45 deg angle with the midline to optimally stimulate the motor
cortex (Brasil-Neto et al. 1992; Mills et al. 1992).
Measures of corticomotoneuronal excitability
Resting motor thresholds. The resting motor threshold (rMT)
was defined as the minimum TMS intensity (measured to the
nearest 1 % of the maximum output of the magnetic stimulator)
required to elicit at least five out of 10 MEP ≥ 50 mV in
consecutive trials (Rossini et al. 1994). TMS stimulus intensities
were expressed relative to rMT measured from the ADM. There
were no statistically significant differences between rMT from the
ADM, APB and FDI. The active motor threshold (aMT) was
defined as the minimum TMS intensity (measured to the nearest
1 % of the maximum output of the magnetic stimulator) required
to elicit at least five out of 10 MEPs ≥ 100 mV in consecutive trials
during background muscle facilitation (5 % maximal isometric
muscle contraction of the ADM; see Kaelin-Lang & Cohen, 2000).
Recruitment curves. Mean MEP amplitudes were obtained in
response to 10 TMS stimuli delivered at each of four stimulus
intensities: 10, 20, 30 and 40 % above rMT in 10 subjects. In three
subjects who demonstrated a significant increase in MEP
amplitude in this first experiment, recruitment curves were also
obtained at 10 randomly intermixed stimulus intensities (step of
5 % absolute stimulator output, six stimuli at each intensity). Based
on these data, a nonlinear regression analysis was implemented
using the Levenberg–Marquard least-mean-squares algorithm
with the Boltzmann function (Devanne et al. 1997; Kaelin-Lang &
Cohen, 2000):
MEPa = P/(1 + exp((I50_I)/k)).
This function is used to relate the amplitude of the response
(MEPa) to the TMS stimulation intensity (I) and has three
different parameters: the function plateau (P), the stimulus
intensity (I50) required to obtain an MEP amplitude 50 % of the
plateau, and the slope parameter k, which is related to the maximal
function steepness (Devanne et al. 1997).
Intracortical inhibition and facilitation. Intracortical inhibition
(ICI) and intracortical facilitation (ICF) were measured with
paired-pulse TMS as previously described (Kujirai et al. 1993;
Ziemann et al. 1996). Briefly, active motor thresholds (aMT) were
determined first. Conditioning stimulus intensity was then set to
90 % of the aMT. The intensity of the test stimulus was that
required to evoke MEPs of approximately 1 mV (often close to
40 % above rMT). The order of presentation of inhibitory (2 ms),
excitatory (15 ms) and control trials (test stimulus alone) intervals
was randomized. Six to eight trials were recorded for each ISI.
Brainstem electrical stimulation. A previous study evaluating the
effects of a 2-h period of somatosensory stimulation on the
responses to TMS and TES under muscle facilitation did not allow
identification of the site of the excitability changes (Ridding et al.
2000). For this reason, we opted to study responses to brainstem
electrical stimulation (BES). We compared motor potentials evoked
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by BES (Ugawa et al. 1991) with those evoked by TMS in two
subjects with a documented increase in TMS-evoked MEPs.
MEPs induced in response to TMS and BES were recorded before
and after the 2-h period of somatosensory stimulation. The order
of presentation of TMS and BES stimuli was randomized. BES
was delivered through surface electrodes from a Digitimer
D180 electrical stimulator (Digitimer Ltd, Hertfordshire, UK).
Stimulating electrodes in a bipolar montage were fixed with
collodion on the skin overlying the mastoids (Ugawa et al. 1991).
MEPs induced in response to TMS (10) and BES (5) were stored
for off-line analysis. Interval between stimuli varied randomly
between 7 and 12 s. Because BES is a painful procedure, only two
subjects were studied.
Effects of lorazepam and dextromethorphan
We investigated the effects of systemic administration of
lorazepam (LZ), a benzodiazepine that facilitates g-aminobutyric
acid A (GABAA) receptor-mediated inhibition (Macdonald &
Kelly, 1995) and of dextromethorphan (DM), a noncompetitive
N-methyl-D-aspartate (NMDA) receptor antagonist (Apland &
Braitman, 1990) on the increased corticomotor excitability elicited
by somatosensory stimulation. Both drugs were administered in a
placebo-controlled double-blind design in separate sessions.
Lorazepam. Pre- and post-intervention measures were obtained
at a time when calculated drug levels were therapeutic. Testing was
first performed 2 h following intake of a single oral dose of LZ
(0.038 mg kg_1 orally) in five subjects. At this time, blood levels
are expected to be within the therapeutic range and remain there
for 3–5 h (Greenblatt et al. 1993). A pharmacokinetic computer
simulation that assumes a two-compartment model with first-
order oral absorption (Gupta et al. 1990) was performed for each
subject (considering individual LZ dose and body weight) to
estimate concentrations before, during, and after the 2-h period of
somatosensory stimulation (WinNonlin v1.5, Pharsight, Mountain
View, CA, USA). Results indicated that LZ concentrations
exceeded 42.9 ng ml_1, well above therapeutic levels (Greenblatt
et al. 1989) in all individuals and intervals tested (range:
42.9–56 mg l_1).
Dextromethorphan. Since DM (2 mg kg_1 orally) rapidly reaches
therapeutic blood levels and has a relatively short half-life (2.5 h)
(Hollander et al. 1994), a single oral dose was administered
30 min preceding the 2-h period of somatosensory stimulation
in six subjects. DM at this dose results in serum and brain
concentrations in humans (Hollander et al. 1994; Steinberg et al.
1996) similar to those that induce NMDA receptor block in vitro
(Apland & Braitman, 1990). Since DM is rapidly metabolized to
dextorphan, a similarly active compound (Hollander et al. 1994),
and brain tissue DM and dextorphan concentrations are much
higher than those present in blood (Steinberg et al. 1996), DM
plasma levels are an imprecise indicator of CNS action (Hollander
et al. 1994) and were not calculated.
Placebo. Placebo was given at exactly the same time as the active
drugs. Because the time of intake was not the same for DM and for
LZ, each drug had its own placebo session. Side-effects were rated
according to the subjects’ self-report as absent, minimal, mild or
moderate.
Statistical analysis
‘GB-Stat’ software (Dynamic Microsystems, Silver Spring, MD,
USA) and ad hoc Labview applications were used for statistical
analysis. Effects of somatosensory stimulation on MEP amplitudes
recorded at four different stimulus intensities were compared
using repeated measures ANOVA with two within-subject factors:
‘time’ (before and after intervention) and ‘intensity’ (four levels).
The focality of the effect was analysed with a two-way ANOVA
model with factors ‘muscle’ (three levels) and ‘time’ (before and
after intervention), and the time course experiment with a one-
way ANOVA (factor ‘time’, four levels). Student’s t test and the
Wilcoxon test were used for post-hoc testing. Recruitment curves
were analysed using a nonlinear regression analysis (Capaday et al.
1999) followed by F-test statistics (Motulsky & Ransnas, 1987).
The significance level was set to P < 0.05 after correction for
multiple comparisons, when required. All results are given as
means ± standard error of the mean (S.E.M.). All ANOVA results
are given with the degree of freedom (d.f.) and the F value.
RESULTS
Effects of somatosensory stimulation on
corticomotoneuronal excitability
A 2-h period of somatosensory stimulation of the ulnar
nerve resulted in significantly increased MEP amplitude
srecorded from the ulnar nerve-innervated ADM muscle
(ANOVA, main factor ‘time’, d.f. = 1, F = 7.91, P < 0.01),
while the control intervention failed to elicit this effect
(Fig. 1).
In the absence of a significant interaction between factors
‘time’ and ‘intensity’ (ANOVA, d.f. = 3, F = 0.8, P = 0.48),
the MEP amplitude increase was more pronounced at
higher levels of stimulation. At 40 % above rMT (Fig. 1B)
MEP amplitudes variably increased in 8 of 10 subjects (on
average by 67.8 ± 23.4 %, range _13 % to +252 %, n = 10).
As expected, ADM amplitudes were significantly higher
at higher stimulation intensities (ANOVA, main factor
‘intensity’, d.f. = 3, F = 3.44, P < 0.05).
A more detailed analysis of recruitment curves (Devanne
et al. 1997) showed that both the plateau (P) (P before:
33.8 % M-response; after: 42.4 % M-response) and the I50
parameters (I50 before: +62.4 % above rMT; after: +53.4 %
above rMT) of the recruitment curve were changed by
somatosensory stimulation while the slope parameter k
remained unchanged (k before: 20.3; after: 21) (Fig. 1C).
The intersession variability of this effect (measured with the
coefficient of variation) within individuals who participated
in three or more experiments (maximum six) ranged
between 9.8 and 49.8 % (average 28.3 %, n = 5 subjects).
The 2-h period of somatosensory stimulation did not
significantly influence: (a) ADM rMT (before: 45.1 ± 1.2 %;
after: 45.1 ± 1.2 %, n = 21); (b) ADM aMT (before:
36.3 ± 1.6 %; after: 36.7 ± 1.4 %, n = 9); (c) intracortical
inhibition (ICI) (ICI before: 47.4 ± 14 %, ICI after:
50.9 ± 8.9 %); or (d) intracortical facilitation (ICF) (ICF
before: 158.9 ± 10.9 %; ICF after: 186.4 ± 42.9 %, n = 5).
Post-hoc power analysis of these data demonstrated that
for a power of 80 % with an alpha error of 5 %, our data
allowed detection of changes as small as 1 % in rMT and
5 % in aMT (absolute stimulator’s output) but only 35 %
in ICI and 115 % in ICF.
Somatosensory stimulation and corticomotor excitabilityJ. Physiol. 540.2 625
Focality of excitability changes elicited by
somatosensory stimulation
In contrast to the MEP amplitudes recorded from the
ADM, MEP amplitudes simultaneously recorded from the
APB muscle, which is innervated by the unstimulated
median nerve, remained unchanged by both the 2-h period
of somatosensory stimulation and the control intervention
(2-h idle time) (Fig. 2). These results were reproducible in
a separate experiment: MEPs were simultaneously recorded
from the FDI, APB, and ADM at a TMS intensity 40 %
above rMT before and after a 2-h period of somatosensory
stimulation. Baseline amplitude of MEPs recorded from
the APB and FDI were often higher than from the ADM
(ANOVA, main factor ‘muscle’, d.f. = 2, F = 3.5, P < 0.05,
Fig. 3C and D).
Stimulation resulted in a highly significant increase in MEP
amplitude (factor ‘time’, d.f. = 1, F = 16.5, P < 0.001).
This effect was significantly different between muscles
(interaction between factor ‘time’ and ‘muscle’: d.f = 2,
F = 4.16, P < 0.05). The increase in amplitude of MEP
recorded from the ulnar nerve-innervated ADM (by
+136 ± 84.1 % of the M-response), while variable (Fig. 3D),
was significantly higher than the increase in MEP amplitude
recorded from both the APB and FDI (which receives
motor innervation from the ulnar nerve but lies in a hand
region with median and radial nerve-mediated somato-
sensory innervation) (Fig. 3).
Duration of excitability changes elicited by somato-
sensory stimulation. The duration of this effect was
investigated in six subjects. Twenty TMS stimuli (inter-
stimulus intervals 5–7 s) were delivered at an intensity of
40 % above rMT before and at three different time
intervals (separated by approximately 10 min) following
somatosensory stimulation. The precise time intervals
varied across individuals because of different times
required to determine optimal scalp positions, relaxation,
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Figure 1. Changes induced by a 2-h period of somatosensory stimulation (A,B,C) or 2 h idle
time (D) on the amplitude of motor evoked potentials (MEPs) recorded from the abductor
digiti minimi (ADM)
A, representative 3-MEP averages evoked by TMS at intensities 10, 20, 30 and 40 % above motor threshold in
one representative experiment, before (thin line) and after (thick line) the 2-h period of somatosensory
stimulation. B, grand average of ADM-MEP amplitude (mean ± S.E.M., n = 10) from all subjects recorded at
TMS intensities 10, 20, 30 and 40 % above motor threshold (1- - - - 1: before intervention; •——•: after 2-h
period of somatosensory stimulation). C, recruitment curve (mean of three subjects) recorded at 10
randomly intermixed TMS intensities before (1) and after (•) the 2-h period of somatosensory stimulation
(mean ± S.E.M.). The dotted line represents the Boltzmann sigmoid function estimated by nonlinear
regression before the 2-h period of somatosensory stimulation; the thick line represents the Boltzmann
function estimated after stimulation. Both curves were significantly different from each other (see Methods
for the statistics used). Amplitude is expressed as a percentage of the supramaximal M-response. *P < 0.05.
D, a control period consisting of a 2-h idle time (without somatosensory stimulation) did not significantly
change the amplitude of MEPs (mean ± S.E.M.) recorded from the ADM at TMS intensities 10, 20, 30 and
40 % above motor threshold (1- - - - 1: before the 2-h idle time; •——•: after 2-h period of idle time;
n = 6).
and perform TMS measurements. To account for these
interindividual differences, we grouped the data into three
time intervals: 8–20, 21–35 and 36–50 min. rMT remained
unchanged. Factor ‘time’ was significant (ANOVA, d.f. = 3,
F = 3, P < 0.01). Post-hoc pair-wise comparisons revealed
that MEPs recorded during the first period were significantly
larger than baseline (+173 ± 51%, Fig. 4) while MEP
amplitudes in the later time intervals only showed a non-
significant trend towards increase (+55 ± 15 and +42 ± 21%,
respectively; see Fig. 4).
Site of changes in motor excitability. A 2-h period of
somatosensory stimulation that resulted in increases in
TMS-evoked MEP amplitudes did not change amplitudes
and areas of the MEPs to BES (Fig. 5) or maximal peripheral
M responses (17.9 ± 3.4 mV before and 18.2 ± 3.7 mV
after stimulation, n = 10).
Effects of LZ and DM
Administration of a single oral dose of LZ significantly
blocked the enhancing effects of a 2-h period of somato-
sensory stimulation on ADM MEP amplitude (ratio of
ADM amplitudes before and after stimulation under LZ:
91.4 ± 12.4 %, n = 5; Fig. 6) while placebo did not modify
the enhancing effect seen in the drug-naive sessions
(ratio of ADM amplitudes before and after stimulation:
185.1 ± 37.8; Fig. 6; see Figs 1–3 for comparison). MEP
amplitudes recorded from APB were similar under LZ before
and after the 2-h period of somatosensory stimulation
(ratio of APB amplitudes before and after stimulation:
97 ± 5.0 %), suggesting stability of corticomotoneuronal
excitability under LZ.
In contrast, the enhancing effects of a 2-h period of
somatosensory stimulation on ADM MEP were unchanged
by DM. There was no significant difference between the DM
(ratio of ADM amplitudes before and after stimulation
under DM: 168.3 ± 26.8 %; Fig. 6) and the corresponding
placebo session (ratio of ADM amplitudes before and after
stimulation: 143.9 ± 10.8 %; Fig. 6). Because one subject,
experiencing side-effects after DM, was unable to relax,
electrophysiological data from only five subjects were
analysed.
The amplitude of SEP components N20–P25 and P25–N33
recorded during somatosensory stimulation was similar
during DM, LZ and placebo sessions, indicating a stable
input into somatosensory cortical regions during each
intervention (Fig. 7). Moreover, SEP amplitudes remained
stable within each session: in both placebo sessions
(N20–P25 early/late: 3.12 ± 0.42 mV/3.77 ± 0.36 mV; P25–
N30: 3.44 ± 0.68 mV/3.58 ± 0.43 mV), DM session (N20–
P25 early/late: 3.27 ± 1 mV/3.63 ± 0.8 mV.; P25–N30:
3.47 ± 1 mV/2.4 ± 0.4 mV) and LZ session (N20–P25
early/late: 2.79 ± 0.5 mV/3.39 ± 0.4 mV; P25–N30: 3.26 ±
0.8 mV/3.35 ± 0.9 mV).
Drowsiness was reported under LZ in all five subjects
tested (three minimal, one mild, one moderate), under
DM in 3/6 subjects (two minimal, one mild) and under
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Figure 2. Changes induced by a 2-h period of
somatosensory stimulation or 2 h idle time on the
amplitude of motor-evoked potentials (MEPs)
recorded from the median nerve-innervated
abductor pollicis brevis (APB)
A, the amplitude of MEPs (mean ± S.E.M.) recorded at TMS
intensities 10, 20, 30 and 40 % above motor threshold from
APB were not significantly changed by the 2-h period of
electrical stimulation of the ulnar nerve (1- - - - 1: before
intervention; •——•: after 2-h period of somatosensory
stimulation; n = 10 subjects). All amplitudes are expressed
as a percentage of the supramaximal M-response. B, a
control period consisting of a 2-h idle time (without
somatosensory stimulation) did not significantly change
the amplitude of MEPs (mean ± S.E.M.) recorded from the
APB at TMS intensities 10, 20, 30 and 40 % above motor
threshold (1- - - -1: before the 2-h idle time; •——•: after
2-h period of idle time; n = 6).
placebo in 2/10 subjects (both minimal). Additionally,
DM elicited dizziness in 3/6 subjects (one minimal, one
mild, one moderate) and nausea in 2/6 subjects (one
minimal, one mild).
DISCUSSION
The new findings of this study are that changes in
corticomotoneuronal excitability elicited by a period of
somatosensory stimulation occur at supraspinal sites and
are markedly influenced by GABAergic mechanisms.
It has been proposed that administration of peripheral
somatosensory stimulation is a useful adjuvant therapy to
promote recovery of motor function in stroke patients
(Johansson et al. 1993; Hamdy & Rothwell, 1998; Powell et
al. 1999; Wong et al. 1999; Conforto et al. 2002). This idea led
to studies that demonstrated and characterized changes in
corticospinal excitability associated with this form of
stimulation in healthy subjects (Hamdy et al. 1998; Ridding
et al. 2000; Stefan et al. 2000). However, the mechanisms
underlying this phenomenon are incompletely understood.
To address this issue, we utilized a previously described
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Figure 3. Comparison of the effect of a 2-h period of somatosensory stimulation on motor
evoked potential (MEP) amplitudes simultaneously recorded from the abductor digiti
minimi (ADM), abductor pollicis brevis (APB) and first dorsal interosseus (FDI)
A, the 2-h period of electrical stimulation of the ulnar nerve typically induced sensation in a region (hatched
area) overlapping the ulnar nerve-innervated ADM but not the ulnar nerve-innervated FDI and the median
nerve-innervated APB. B, grand average across all subjects (n = 6) of the individually normalized increase in
MEP amplitude (MEP peak-to-peak amplitude before intervention set to 100 %) after a 2-h period of
somatosensory stimulation. Only MEP amplitude recorded from the ADM was significantly (P < 0.05)
larger after the 2-h period of electrical stimulation. C, representative 3-MEP averages from a typical
experiment before the intervention (thin line) and after the intervention (thick line) simultaneously
recorded from the ADM, FDI (middle trace) and APB (traces on the right-hand side). D, MEP amplitudes
(expressed as percentages of the maximal peripheral M-response) recorded from the ADM, FDI and APB,
before (dots on the left of each line) and after (dots on the right of each line) a 2-h period of somatosensory
stimulation in all six subjects (each line is one experiment).
Figure 4. Time course of the increase in the
amplitude of motor-evoked potentials (MEP)
recorded from the abductor digiti minimi (ADM)
induced by a 2-h period of somatosensory
stimulation (mean ± S.E.M., n = 6)
The individually normalized MEP amplitude (as a
percentage of pre-intervention values: MEP peak-to-peak
amplitude before intervention set to 100 %) was only
significantly larger than baseline in the 8- to 20-min period
following the intervention. *P < 0.05.
protocol in which measures of corticomotoneuronal
excitability are tested before and after a 2-h period of
electrical stimulation of the ulnar nerve leading to increased
MEP amplitudes (Ridding et al. 2000). Consistent with this
previous report, we identified an increased MEP amplitude
in response to TMS elicited by a 2-h period of somato-
sensory stimulation in the absence of changes in the
unstimulated control condition (2 h idle time). A more
detailed analysis of the input–output curves (Devanne et
al. 1997), a sensitive measure of corticospinal excitability
(Ridding & Rothwell, 1997; Boroojerdi et al. 2001), further
substantiated this finding. The factors influencing the
interindividual and intersession variability demonstrated
in this study remain to be determined.
Additionally, we found no changes in rMT, aMT, ICI or
ICF. While our study was powered to identify small changes
in rMT and aMT, we could only expect to detect changes
larger than 35 % in ICI and 115 % in ICF. Therefore,
more subtle modifications in ICI and ICF as a consequence
of somatosensory stimulation would not be apparent.
While MEP amplitudes from the ulnar nerve-innervated
ADM increased, those recorded from the median nerve-
innervated APB did not. Interestingly, MEP amplitudes
from the FDI remained unaffected by ulnar nerve
stimulation. Motor output and muscle afferents to and
from FDI are conducted through the ulnar nerve, while
cutaneous and joint afferents are carried through the median
and radial nerves (see Rossini et al. 1996). Therefore,
electrical stimulation of the ulnar nerve stimulated muscle
afferents from the FDI. This stimulation failed to elicit
significant changes in MEP amplitudes from this muscle.
These findings suggest a focal somatotopic effect in
which somatosensory inputs other than muscle afferents
are important for mediating the corticomotoneuronal
excitability changes observed in our study, an observation
consistent with previous reports (Rossini et al. 1996; Rossi
et al. 1998).
Site of the corticospinal excitability changes
Excitability changes mediating these results can occur at
cortical and/or subcortical sites. To address this issue, we
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Figure 5. Comparison of the effects of a 2-h period of somatosensory stimulation on motor-
evoked potential (MEPs) evoked by transcranial magnetic stimulation (TMS) and brainstem
electrical stimulation (BES) recorded from the abductor digiti minimi (ADM)
A and B, each trace represents the mean of five consecutive MEPs recorded before and after the 2-h period of
somatosensory stimulation from two subjects. The increase in amplitude of TMS-evoked MEPs induced by a
2-h period of somatosensory stimulation was significant whereas the amplitude of potentials evoked by BES
was not significantly changed by the intervention.
Figure 6. Effects of dextromethorphan (DM) and
lorazepam (LZ) on the change in amplitude induced by a
2-h period of somatosensory stimulation
MEP amplitude changes relative to pre-intervention values
(mean ± S.E.M.) in abductor digiti minimi (ADM; TMS intensity
40 % above rMT; n = 5). Note that LZ blocked the effects of SS
stimulation relative to the placebo session. The effect of a 2-h
period of somatosensory stimulation was not significantly different
under the effects of DM than under the effects of placebo (P, on the
left). In contrast, LZ significantly (P < 0.05) blocked the effects of a
2-h period of somatosensory stimulation compared with the
placebo session (P, on the right).
recorded MEPs in response to TMS and to BES, as well as
maximal peripheral M responses before and after the 2-h
stimulation period. This intervention did not modify the
amplitude of maximal peripheral M responses or MEPs
in response to BES, suggesting the lack of significant
excitability changes at muscle, neuromuscular junction or
spinal cord structures below the brainstem level, an
interpretation consistent with the previously reported
stability of F-waves (Ridding et al. 2000). In contrast,
somatosensory stimulation resulted in substantial amplitude
increase in MEPs in response to TMS. TMS stimulates
predominantly corticocortical connections targeting
pyramidal tract neurons (Day et al. 1989; Ridding &
Rothwell, 1997; Cracco et al. 1999) whereas BES excites
(eliciting only one descending volley) descending motor
axons directly at the brainstem level (Ugawa et al. 1991).
Taken together, these findings indicate that a sustained
period of somatosensory stimulation exerts its modulatory
effect on motor excitability predominantly in the motor
cortex. However, we cannot exclude weaker concomitant
changes in excitability at the spinal level.
The sensorimotor interactions leading to this change in
motor cortical excitability could occur in different cortical
and/or subcortical structures and only secondarily influence
the motor cortex excitability. First, it is conceivable that
the stimulation period elicited increased excitability in the
somatosensory ‘ventrolateral pars oralis’ thalamic nucleus
or in the primary somatosensory cortex. However, the
stability of SEP amplitudes during the stimulation period
argues against this hypothesis. It is also unlikely that the
‘ventrolateral pars caudalis’ thalamic nucleus which also
receives somatosensory information and is linked by direct
projections to the primary motor cortex, is the site for such
interaction because the connections between this thalamic
nucleus and the primary motor cortex are diffuse (Asanuma
et al. 1980) and therefore cannot explain the focality of the
effect described here. It is more plausible that the site of
this interaction is the motor cortex itself which receives
somatotopically organized projections from the primary
somatosensory cortex in animals (Kaneko et al. 1994a,b)
and humans (Terao et al. 1999) that participate in learning
new motor skills (Pavlides et al. 1993). It is also possible that
other structures of the motor system which receive somato-
topically organized somatosensory inputs (e.g. cerebellum
or premotor cortical areas) are involved in this sensorimotor
interaction.
Candidate mechanisms
GABA, the main inhibitory neurotransmitter in the brain,
is actively involved in experience-dependent cerebral
reorganization (Zheng & Knudsen, 1999; Feldman, 2000).
As an example, changes in somatosensory input elicited by
nerve transection result in rapid modifications in cortical
maps that are associated with reduced GABA levels
(Garraghty et al. 1991; Myers et al. 2000). In the motor
cortex, similarly rapid changes in motor maps are mimicked
by injection of the GABA antagonist bicucculine (Jacobs &
Donoghue, 1991). In humans, deafferentation-induced
changes in motor cortex excitability (Ziemann et al. 1998)
are also associated with decreased cortical GABA (Levy et
al. 1999). Overall, it is conceivable that a modulation of
cortical GABAergic neurotransmission mediates the
changes described in this study. Our results demonstrated
that a pharmacological manipulation that enhances
GABAergic function (Macdonald & Kelly, 1995) blocked
changes in corticomotoneuronal excitability elicited by
somatosensory stimulation, providing support for this
hypothesis. The same pharmacological approach has
been successfully utilized to identify the involvement of
GABAergic influences on deafferentation-induced plasticity
(Ziemann et al. 1998) and use-dependent plasticity
(Bütefisch et al. 2000).
In contrast, our results showed that DM did not modify
excitability changes elicited by a 2-h period of somatosensory
stimulation. At the given doses, DM results in brain
concentrations (Hollander et al. 1994; Steinberg et al.
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Figure 7. Amplitude (in mV) of the early components
(N1 : N20, P1 : P25, N2 : N30) of somatosensory-evoked
potentials (SEP) recorded during the 2-h period of
somatosensory stimulation under the action of
dextromethorphan (DM), lorazepam (LZ), and the
corresponding placebo (P) sessions
A, each trace is the mean of 300–400 trials recorded in the same
representative subject during the 2-h period of somatosensory
stimulation (arrows indicate the early components N1, P1, N2
used for the analysis). B, grand average across all subjects (n = 5,
mean ± S.E.M.) of the N1–P1 amplitude (4) and P1–N2 amplitude
(5). Neither DM nor LZ significantly modified SEP amplitude
compared with placebo.
1996) similar to those that induce NMDA receptor block
in vitro (Apland & Braitman, 1990), and elicits side-effects
similar to those observed in our study which are consistent
with active NMDA receptor block action (Hollander et al.
1994; Steinberg et al. 1996). The lack of effect of DM
observed in this study contrasts with the strong antagonistic
effects of identical doses of DM on use-dependent plasticity
induced by training in humans (Butefisch et al. 2000). These
results suggest that long- or short-term potentiation-like
mechanisms thought to be operational in the setting of
use-dependent plasticity (Butefisch et al. 2000) are less
involved in excitability changes elicited by somatosensory
stimulation. Experiments in animal models are required to
gain additional insight on this issue.
The amplitude and latency of early cortical components of
SEP to ulnar nerve stimulation under the effects of LZ, did
not differ from those obtained under placebo or DM,
suggesting stable somatosensory input across conditions.
Additionally, attentional levels across conditions were
comparable, a conclusion also supported by the lack of
amplitude changes in the N30 component of SEP, known
to be modulated by mental activity (Cheron & Borenstein,
1992). Pre- (baseline) and post-intervention MEPs were
recorded at a time when the pharmacokinetic computer
simulation demonstrated stable therapeutic concentrations
of LZ (see Methods). Finally, it is unlikely that the effect of
LZ was mediated by nonspecific sedative effects only, since
both DM and LZ produced qualitatively similar drowsiness
but only LZ blocked motor excitability changes. Hence,
the changes in motor cortical excitability induced by a 2-h
period of somatosensory stimulation are predominantly
influenced by GABAergic function, and much less
affected, if at all, by NMDA receptor function. This finding
is consistent with the hypothesis that a 2-h period of
somatosensory stimulation may modulate GABAergic
cortical function, decreasing cortical GABAergic inhibition.
Such a decrease is known to facilitate plasticity in animals
(Jacobs & Donoghue, 1991) and in humans (Ziemann et
al. 2001) and may be a factor contributing to better
functional recovery observed when physical therapy is
performed in association with somatosensory stimulation
after stroke (Johansson et al. 1993).
In conclusion, this study demonstrates that a sustained
period of nonpainful peripheral electrical stimulation
increases corticomotoneuronal excitability, most likely by
acting somatotopically in the motor cortex, and is
significantly influenced by GABAergic function.
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